{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:57:27Z","timestamp":1777888647886,"version":"3.51.4"},"reference-count":370,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,20]],"date-time":"2027-02-20T00:00:00Z","timestamp":1803081600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA030256"],"award-info":[{"award-number":["R01 AA030256"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH104603"],"award-info":[{"award-number":["R01 MH104603"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aggression and Violent Behavior"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.avb.2026.102139","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:59:57Z","timestamp":1770710397000},"page":"102139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting serotonin 5-HT2A receptors in the treatment of aggression: From antipsychotics to psychedelics"],"prefix":"10.1016","volume":"87","author":[{"given":"Simona","family":"Scheggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Braccagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Branca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bortolato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.avb.2026.102139_bb0005","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.1090-09.2009","article-title":"PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors","volume":"29","author":"Abbas","year":"2009","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"2\u20133","key":"10.1016\/j.avb.2026.102139_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.bjp.0704747","article-title":"Differences in potency and efficacy of a series of phenylisopropylamine\/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors","volume":"136","author":"Acu\u00f1a-Castillo","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/YIC.0000000000000206","article-title":"Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: An open-label uncontrolled study","volume":"33","author":"Aguglia","year":"2018","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2014.07.103","article-title":"A systematic review of clozapine induced cardiomyopathy","volume":"176","author":"Alawami","year":"2014","journal-title":"International Journal of Cardiology"},{"issue":"Suppl. 2","key":"10.1016\/j.avb.2026.102139_bb0030","first-page":"5","article-title":"Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb0035","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4088\/JCP.10m06011yel","article-title":"Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial","volume":"72","author":"Allen","year":"2011","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.64719\/pb.4353","article-title":"Asenapine for the control of physical aggression: A prospective naturalist pilot study","volume":"47","author":"Amon","year":"2017","journal-title":"Psychopharmacology Bulletin"},{"issue":"2\u20133","key":"10.1016\/j.avb.2026.102139_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pscychresns.2005.05.016","article-title":"Orbitofrontal correlates of aggression and impulsivity in psychiatric patients","volume":"147","author":"Antonucci","year":"2006","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0306-4522(91)90128-B","article-title":"5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex","volume":"40","author":"Araneda","year":"1991","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.avb.2026.102139_bb0060","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00004583-200312000-00011","article-title":"Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials","volume":"42","author":"Arnold","year":"2003","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00427492","article-title":"The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats","volume":"80","author":"Baggio","year":"1983","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/YIC.0000000000000060","article-title":"Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012)","volume":"30","author":"Balda","year":"2015","journal-title":"International Clinical Psychopharmacology"},{"issue":"7496","key":"10.1016\/j.avb.2026.102139_bb0075","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer\u2019s disease: Randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117792","article-title":"Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits","volume":"10","author":"Banlaki","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-007-0780-5","article-title":"Anti-aggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of mice","volume":"193","author":"Bannai","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb0090","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/cap.2006.16.665","article-title":"The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s)","volume":"16","author":"Barzman","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"Suppl. 10","key":"10.1016\/j.avb.2026.102139_bb0100","first-page":"7","article-title":"Efficacy of olanzapine: An overview of pivotal clinical trials","volume":"58","author":"Beasley","year":"1997","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0105","first-page":"120","article-title":"A high-resolution in vivo atlas of the human brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0091-3057(95)00077-A","article-title":"Differential effects of CGS 12066B and CP-94,253 on murine social and agonistic behaviour","volume":"52","author":"Bell","year":"1995","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0115","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4088\/JCP.v67n0705","article-title":"Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study","volume":"67","author":"Bellino","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.v59n0302","article-title":"Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder","volume":"59","author":"Benedetti","year":"1998","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.1998.tb10181.x","article-title":"Interactions between effectors linked to serotonin receptors","volume":"861","author":"Berg","year":"1998","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.avb.2026.102139_bb0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annual Review of Medicine"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/cap.2023.0097","article-title":"Clozapine treatment for aggressive behaviors in youths with neurodevelopmental disorders","volume":"34","author":"Berloffa","year":"2024","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb0140","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/cercor\/bhu101","article-title":"Orbitofrontal cortex reactivity to angry facial expression in a social interaction correlates with aggressive behavior","volume":"25","author":"Beyer","year":"2015","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.avb.2026.102139_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111588","article-title":"Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor","volume":"127","author":"Billard","year":"2025","journal-title":"Cellular Signalling"},{"issue":"17","key":"10.1016\/j.avb.2026.102139_bb0150","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1523\/JNEUROSCI.3234-17.2018","article-title":"Task division within the prefrontal cortex: Distinct neuron populations selectively control different aspects of aggressive behavior via the hypothalamus","volume":"38","author":"Biro","year":"2018","journal-title":"The Journal of Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(88)90172-2","article-title":"Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex","volume":"453","author":"Blue","year":"1988","journal-title":"Brain Research"},{"key":"10.1016\/j.avb.2026.102139_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/7854_2016_464","article-title":"Therapeutic applications of classic hallucinogens","volume":"36","author":"Bogenschutz","year":"2018","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1016\/j.avb.2026.102139_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2010.11.055","article-title":"Distribution of 5-HT2A receptor immunoreactivity in the rat amygdaloid complex and colocalization with \u03b3-aminobutyric acid","volume":"1370","author":"Bombardi","year":"2011","journal-title":"Brain Research"},{"issue":"2\u20133","key":"10.1016\/j.avb.2026.102139_bb0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.brainresbull.2011.11.006","article-title":"Neuronal localization of 5-HT2A receptor immunoreactivity in the rat hippocampal region","volume":"87","author":"Bombardi","year":"2012","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.avb.2026.102139_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fphar.2014.00068","article-title":"Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex","volume":"5","author":"Bombardi","year":"2014","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00429-012-0406-5","article-title":"Serotonergic innervation and serotonin receptor expression of NPY-producing neurons in the rat lateral and basolateral amygdaloid nuclei","volume":"218","author":"Bonn","year":"2013","journal-title":"Brain Structure & Function"},{"issue":"13","key":"10.1016\/j.avb.2026.102139_bb0185","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/npp.2011.157","article-title":"Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology: Official publication of the American college of","volume":"36","author":"Bortolato","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2013.01.015","article-title":"The role of the serotonergic system at the interface of aggression and suicide","volume":"236","author":"Bortolato","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.avb.2026.102139_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-0-12-386467-3.00002-9","article-title":"Behavioral outcomes of monoamine oxidase deficiency: Preclinical and clinical evidence","volume":"100","author":"Bortolato","year":"2011","journal-title":"International Review of Neurobiology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0006-3223(00)01018-0","article-title":"Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice","volume":"49","author":"Bouwknecht","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb0205","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40263-017-0458-4","article-title":"Efficacy and tolerability of Asenapine compared with olanzapine in borderline personality disorder: An open-label randomized controlled trial","volume":"31","author":"Bozzatello","year":"2017","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00406-022-01480-y","article-title":"Elevated levels of serotonin 5-HT2A receptors in the orbitofrontal cortex of antisocial individuals","volume":"273","author":"Braccagni","year":"2023","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0215","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists","volume":"70","author":"Braden","year":"2006","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.mp.4001366","article-title":"The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain","volume":"9","author":"Bray","year":"2004","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","volume":"64","author":"Brodaty","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0235","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1092852914000157","article-title":"Clozapine: An effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital","volume":"19","author":"Brown","year":"2014","journal-title":"CNS Spectrums"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1781(79)90053-2","article-title":"Aggression in humans correlates with cerebrospinal fluid amine metabolites","volume":"1","author":"Brown","year":"1979","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0245","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1523\/JNEUROSCI.20-05-01952.2000","article-title":"Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: Relation of the 5-HT transporter to amphetamine-induced neurotoxicity","volume":"20","author":"Brown","year":"2000","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0250","first-page":"607","article-title":"Violence and schizophrenia: Clozapine as a specific antiaggressive agent","volume":"23","author":"Buckley","year":"1995","journal-title":"The Bulletin of the American Academy of Psychiatry and the Law"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0255","first-page":"173","article-title":"Aggression and schizophrenia: Efficacy of risperidone","volume":"25","author":"Buckley","year":"1997","journal-title":"The Journal of the American Academy of Psychiatry and the Law"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00104-X","article-title":"The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain","volume":"676","author":"Burnet","year":"1995","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40101-018-0171-0","article-title":"Serotonergic gene polymorphisms (5-HTTLPR, 5HTR1A, 5HTR2A), and population differences in aggression: Traditional (Hadza and Datoga) and industrial (Russians) populations compared","volume":"37","author":"Butovskaya","year":"2018","journal-title":"Journal of Physiological Anthropology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2013.05.004","article-title":"MAOA, childhood maltreatment, and antisocial behavior: Meta-analysis of a gene-environment interaction","volume":"75","author":"Byrd","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb0275","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3389\/fphar.2019.01465","article-title":"The use of antipsychotic drugs for treating behavioral symptoms in Alzheimer\u2019s disease","volume":"10","author":"Calsolaro","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0280","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/jpet.113.208637","article-title":"Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands","volume":"347","author":"Canal","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6579","key":"10.1016\/j.avb.2026.102139_bb0285","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.avb.2026.102139_bb0290","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22662.1","article-title":"New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer\u2019s disease: Focus on brexpiprazole and pimavanserin","volume":"9","author":"Caraci","year":"2020","journal-title":"F1000Research"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0295","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"The Lancet. Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb0300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Frontiers in Human Neuroscience"},{"key":"10.1016\/j.avb.2026.102139_bb0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ibneur.2020.11.001","article-title":"Region- and receptor-specific effects of chronic social stress on the central serotonergic system in mice","volume":"10","author":"Carneiro-Nascimento","year":"2021","journal-title":"IBRO Neuroscience Reports"},{"issue":"5582","key":"10.1016\/j.avb.2026.102139_bb0310","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1072290","article-title":"Role of genotype in the cycle of violence in maltreated children","volume":"297","author":"Caspi","year":"2002","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.avb.2026.102139_bb0315","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/gps.504","article-title":"A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients","volume":"16","author":"Chan","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0320","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4088\/JCP.v60n0710","article-title":"Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder","volume":"60","author":"Chengappa","year":"1999","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb0325","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/070674370004500907","article-title":"Impact of risperidone on seclusion and restraint at a state psychiatric hospital","volume":"45","author":"Chengappa","year":"2000","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0330","first-page":"269","article-title":"Effects of clozapine on use of seclusion and restraint at a state hospital","volume":"45","author":"Chiles","year":"1994","journal-title":"Hospital & Community Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/00048677609159524","article-title":"Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness","volume":"10","author":"Chiu","year":"1976","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"issue":"29","key":"10.1016\/j.avb.2026.102139_bb0340","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1523\/JNEUROSCI.3317-17.2018","article-title":"Stimulation of the prefrontal cortex reduces intentions to commit aggression: A randomized, double-blind, placebo-controlled, stratified, parallel-group trial","volume":"38","author":"Choy","year":"2018","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"12","key":"10.1016\/j.avb.2026.102139_bb0345","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.4088\/JCP.v68n1207","article-title":"Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: A quantitative review of efficacy and safety","volume":"68","author":"Citrome","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb0350","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/14656566.2011.626769","article-title":"A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia","volume":"13","author":"Citrome","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0355","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14355","article-title":"Efficacy of HP-3070, an Asenapine transdermal system, on symptoms of hostility in adults with schizophrenia: A post hoc analysis of a 6-week phase 3 study","volume":"83","author":"Citrome","year":"2022","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb0360","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.2147\/NDT.S149376","article-title":"Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder","volume":"13","author":"Citrome","year":"2017","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb0365","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1176\/appi.ps.52.11.1510","article-title":"Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia","volume":"52","author":"Citrome","year":"2001","journal-title":"Psychiatric Services (Washington, D.C.)"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0370","doi-asserted-by":"crossref","first-page":"170","DOI":"10.64719\/pb.4247","article-title":"The 5-HT1B receptor: Behavioral implications","volume":"35","author":"Clark","year":"2001","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0375","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4088\/JCP.v62n0108","article-title":"The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer\u2019s disease","volume":"62","author":"Clark","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0380","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s002130050061","article-title":"Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression","volume":"148","author":"Cleare","year":"2000","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0385","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S1092852915000310","article-title":"Serotonin and impulsive aggression","volume":"20","author":"Coccaro","year":"2015","journal-title":"CNS Spectrums"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0390","first-page":"393","article-title":"Buspirone challenge: Preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans","volume":"26","author":"Coccaro","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0400","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biopsych.2006.08.024","article-title":"Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression","volume":"62","author":"Coccaro","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb0405","first-page":"440","article-title":"The use of clozapine in a mentally retarded and aggressive population","volume":"55","author":"Cohen","year":"1994","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0410","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/cap.2006.0007","article-title":"Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder","volume":"18","author":"Connor","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/104012371702900203","article-title":"Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting","volume":"29","author":"Correll","year":"2017","journal-title":"Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0425","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0996-98","article-title":"Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors","volume":"14","author":"Crabbe","year":"1996","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100059","article-title":"5-HT2A receptors: Pharmacology and functional selectivity","volume":"77","author":"Cummins","year":"2025","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0435","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004714-199508000-00002","article-title":"Effect of risperidone on hostility in schizophrenia","volume":"15","author":"Czobor","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0440","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2021.05.016","article-title":"The modulatory role of serotonin on human impulsive aggression","volume":"90","author":"da Cunha-Bang","year":"2021","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0445","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pscychresns.2012.09.007","article-title":"Trait aggression and trait impulsivity are not related to frontal cortex 5-HT2A receptor binding in healthy individuals","volume":"212","author":"da Cunha-Bang","year":"2013","journal-title":"Psychiatry Research"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0450","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF02147990","article-title":"Localization of monoamines in the lower brain stem","volume":"20","author":"Dahlstr\u00f6m","year":"1964","journal-title":"Experientia"},{"key":"10.1016\/j.avb.2026.102139_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1292877","article-title":"Genetic polymorphism in HTR2A rs6313 is associated with internet addiction disorder","volume":"15","author":"Dai","year":"2024","journal-title":"Frontiers in Psychiatry"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb0460","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","article-title":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: A randomized, double-blind, placebo-controlled pilot study","volume":"235","author":"Danforth","year":"2018","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0465","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-006-0333-3","article-title":"5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behavior in mice","volume":"185","author":"De Almeida","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.avb.2026.102139_bb0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2005.09.065","article-title":"5-HT1A and 5-HT1B receptor agonists and aggression: A pharmacological challenge of the serotonin deficiency hypothesis","volume":"526","author":"de Boer","year":"2005","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eurpsy.2005.11.003","article-title":"Risperidone in the management of agitation and aggression associated with psychiatric disorders","volume":"21","author":"De Deyn","year":"2006","journal-title":"European Psychiatry: The Journal of the Association of European Psychiatrists"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0480","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gps.1032","article-title":"Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer\u2019s disease","volume":"19","author":"De Deyn","year":"2004","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0485","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clineuro.2005.03.013","article-title":"Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone","volume":"107","author":"De Deyn","year":"2005","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0490","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0495","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0005-7967(96)00018-6","article-title":"The expression of anger and its consequences","volume":"34","author":"Deffenbacher","year":"1996","journal-title":"Behaviour Research and Therapy"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0500","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1124\/jpet.111.187534","article-title":"S32212, a novel serotonin type 2C receptor inverse agonist\/\u03b12-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization","volume":"340","author":"Dekeyne","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0505","first-page":"23","article-title":"Parenteral loxapine in severely disturbed schizophrenic patients","volume":"41","author":"Deniker","year":"1980","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0510","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1039856213491990","article-title":"Clozapine and agranulocytosis: Re-assessing the risks","volume":"21","author":"Drew","year":"2013","journal-title":"Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0515","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/PL00005736","article-title":"Neocortical activation: Modulation by multiple pathways acting on central cholinergic and serotonergic systems","volume":"116","author":"Dringenberg","year":"1997","journal-title":"Experimental Brain Research"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0520","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1037\/a0031544","article-title":"Revisiting the serotonin-aggression relation in humans: A meta-analysis","volume":"139","author":"Duke","year":"2013","journal-title":"Psychological Bulletin"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0525","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/mol.114.093476","article-title":"Role of SAP97 in the regulation of 5-HT2AR endocytosis and signaling","volume":"86","author":"Dunn","year":"2014","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0530","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11055-014-9905-6","article-title":"Neurotransmitter mechanisms of context-dependent behavior","volume":"44","author":"D\u2019yakonova","year":"2014","journal-title":"Neuroscience and Behavioral Physiology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0535","first-page":"271","article-title":"Patient response to clozapine in a forensic psychiatric hospital","volume":"45","author":"Ebrahim","year":"1994","journal-title":"Hospital & Community Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0545","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.mehy.2012.10.014","article-title":"The dopamine D4\/D2 receptor antagonist affinity ratio as a predictor of anti-aggression medication efficacy","volume":"80","author":"El-Mallakh","year":"2013","journal-title":"Medical Hypotheses"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0550","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12017-010-8138-2","article-title":"Functional genomics of serotonin receptor 2A (HTR2A): Interaction of polymorphism, methylation, expression and disease association","volume":"13","author":"Falkenberg","year":"2011","journal-title":"Neuromolecular Medicine"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0555","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12031-009-9320-6","article-title":"Identification of a potential molecular Link between the glucocorticoid and serotonergic signaling systems","volume":"41","author":"Falkenberg","year":"2010","journal-title":"Journal of Molecular Neuroscience"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0560","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/cap.2018.0115","article-title":"Atypical antipsychotics for irritability in pediatric autism: A systematic review and network Meta-analysis","volume":"29","author":"Fallah","year":"2019","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0565","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1037\/0893-3200.22.3.429","article-title":"Associations of substance use problems with intimate partner violence for at-risk men in long-term relationships","volume":"22","author":"Feingold","year":"2008","journal-title":"Journal of Family Psychology: JFP: Journal of the Division of Family Psychology of the American Psychological Association (Division 43)"},{"issue":"8\u20139","key":"10.1016\/j.avb.2026.102139_bb0570","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/j.1552-4604.1982.tb02687.x","article-title":"Loxapine succinate as initial treatment of hostile and aggressive schizophrenic criminal offenders","volume":"22","author":"Feldman","year":"1982","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.110.085993","article-title":"Life stress, 5-HTTLPR and mental disorder: Findings from a 30-year longitudinal study","volume":"198","author":"Fergusson","year":"2011","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0580","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02439581","article-title":"Effects of imidazole and some imidazole-derivatives on lisuride-induced mounting and aggressiveness","volume":"93","author":"Ferrari","year":"1987","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0585","first-page":"509","article-title":"A double-blind pilot study of risperidone in the treatment of conduct disorder","volume":"39","author":"Findling","year":"2000","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0590","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/PL00005484","article-title":"Aggression heightened by alcohol or social instigation in mice: Reduction by the 5-HT(1B) receptor agonist CP-94,253","volume":"146","author":"Fish","year":"1999","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0595","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0010-440X(93)90065-C","article-title":"Clozapine treatment of borderline patients: A preliminary study","volume":"34","author":"Frankenburg","year":"1993","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0600","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/104012371302500207","article-title":"A case series of clozapine for borderline personality disorder","volume":"25","author":"Frogley","year":"2013","journal-title":"Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists"},{"key":"10.1016\/j.avb.2026.102139_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110622","article-title":"Serotonin 2A (5-HT2A) receptor as evolving biological target: Function, structure, ligands and role in the therapy of neuropsychiatric diseases","volume":"279","author":"Fryc","year":"2025","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0615","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000077367","article-title":"Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type","volume":"49","author":"Fujikawa","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb0620","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1440-1681.2007.04688.x","article-title":"Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart","volume":"34","author":"Garc\u00eda","year":"2007","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0625","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/acps.12193","article-title":"Practitioner attitudes to clozapine initiation","volume":"130","author":"Gee","year":"2014","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0630","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/cap.1992.2.291","article-title":"An open clinical trial of trazodone in aggressive children","volume":"2","author":"Ghaziuddin","year":"1992","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb0635","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jad.2006.05.016","article-title":"Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene","volume":"96","author":"Giegling","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0640","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acsptsci.3c00192","article-title":"Comparative pharmacological effects of Lisuride and lysergic acid diethylamide revisited","volume":"7","author":"Glatfelter","year":"2024","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"Suppl. 3","key":"10.1016\/j.avb.2026.102139_bb0645","first-page":"8","article-title":"Clozapine reduces violence and persistent aggression in schizophrenia","volume":"59","author":"Glazer","year":"1998","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"25","key":"10.1016\/j.avb.2026.102139_bb0650","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sciences"},{"issue":"2\u20133","key":"10.1016\/j.avb.2026.102139_bb0655","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(83)90464-8","article-title":"Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists","volume":"91","author":"Glennon","year":"1983","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.01.028","article-title":"Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation","volume":"159","author":"Godar","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb0665","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fnhum.2015.00575","article-title":"Serotonin receptor gene (HTR2A) T102C polymorphism modulates individuals\u2019 perspective taking ability and autistic-like traits","volume":"9","author":"Gong","year":"2015","journal-title":"Frontiers in Human Neuroscience"},{"issue":"8","key":"10.1016\/j.avb.2026.102139_bb0670","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/092986709787581851","article-title":"Agonist-trafficking and hallucinogens","volume":"16","author":"Gonz\u00e1lez-Maeso","year":"2009","journal-title":"Current Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0675","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0680","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.46.5.1231","article-title":"Frontal lobe injuries, violence, and aggression: A report of the Vietnam head injury study","volume":"46","author":"Grafman","year":"1996","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.avb.2026.102139_bb0685","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.avb.2026.102139_bb0690","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jad.2024.07.103","article-title":"Comprehensive analysis of adverse events associated with pimavanserin using the FAERS database","volume":"362","author":"Gu","year":"2024","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.avb.2026.102139_bb0695","series-title":"StatPearls","article-title":"Clozapine","author":"Haidary","year":"2025"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0700","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X","article-title":"Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907","volume":"38","author":"Hall","year":"2000","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.avb.2026.102139_bb0705","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neubiorev.2017.09.017","article-title":"The role of central and medial amygdala in normal and abnormal aggression: A review of classical approaches","volume":"85","author":"Haller","year":"2018","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0710","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neubiorev.2005.01.005","article-title":"Normal and abnormal aggression: Human disorders and novel laboratory models","volume":"30","author":"Haller","year":"2006","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0715","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1005626100084","article-title":"Brief report: Effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation","volume":"31","author":"Hammock","year":"2001","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.avb.2026.102139_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109637","article-title":"Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors","volume":"94","author":"Hartmann","year":"2019","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb0725","first-page":"154","article-title":"Seroquel\u2019\u00ae: An effective atypical antipsychotic with no greater EPS than placebo across the full dose range","volume":"29","author":"Hellewell","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.avb.2026.102139_bb0730","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.1997.tb52354.x","article-title":"Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission","volume":"836","author":"Higley","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0735","first-page":"91","article-title":"The discovery of LSD and subsequent investigations on naturally occurring hallucinogens","volume":"8","author":"Hofmann","year":"1970"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0740","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/cap.2006.16.541","article-title":"A double-blind placebo-controlled pilot study of olanzapine in childhood\/adolescent pervasive developmental disorder","volume":"16","author":"Hollander","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0745","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/acschemneuro.5b00033","article-title":"Epigenetic mechanisms of serotonin signaling","volume":"6","author":"Holloway","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0750","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/ps.47.1.52","article-title":"Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis","volume":"47","author":"Honigfeld","year":"1996","journal-title":"Psychiatric Services (Washington, D.C.)"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb0755","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0269881113494106","article-title":"Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala","volume":"27","author":"Hornboll","year":"2013","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0760","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jchemneu.2003.10.002","article-title":"The human raphe nuclei and the serotonergic system","volume":"26","author":"Hornung","year":"2003","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0765","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","article-title":"MDMA enhances \u201cmind reading\u201d of positive emotions and impairs \u201cmind reading\u201d of negative emotions","volume":"222","author":"Hysek","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb0770","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70109","article-title":"Evidence that 5-HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs","author":"Ippolito","year":"2025","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0775","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0780","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpsychires.2011.09.001","article-title":"The CC genotype in HTR2A T102C polymorphism is associated with behavioral impulsivity in alcohol-dependent patients","volume":"46","author":"Jakubczyk","year":"2012","journal-title":"Journal of Psychiatric Research"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0785","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: Guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.avb.2026.102139_bb0790","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbr.2013.07.044","article-title":"Serotonin\u2082a\/C receptors mediate the aggressive phenotype of TLX gene knockout mice","volume":"256","author":"Ju\u00e1rez","year":"2013","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0795","doi-asserted-by":"crossref","first-page":"43","DOI":"10.9758\/cpn.2019.17.1.43","article-title":"Clozapine in the treatment of aggression in conduct disorder in children and adolescents: A randomized, double-blind, controlled trial","volume":"17","author":"Ju\u00e1rez-Trevi\u00f1o","year":"2019","journal-title":"Clinical Psychopharmacology and Neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb2795","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb0800","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0805","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0031-9384(00)00374-7","article-title":"High social anxiety and low aggression in fawn-hooded rats","volume":"71","author":"Kantor","year":"2000","journal-title":"Physiology & Behavior"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0810","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M113.036558","article-title":"Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists","volume":"13","author":"Karaki","year":"2014","journal-title":"Molecular & Cellular Proteomics: MCP"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0815","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. Risperidone study group","volume":"60","author":"Katz","year":"1999","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0820","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0000000000000345","article-title":"Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms","volume":"35","author":"Kelly","year":"2015","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0825","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/jnp.2006.18.4.547","article-title":"A pilot study of quetiapine treatment of aggression due to traumatic brain injury","volume":"18","author":"Kim","year":"2006","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"21","key":"10.1016\/j.avb.2026.102139_bb0830","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115697","article-title":"In vivo serotonin 5-HT2A receptor availability and its relationship with aggression traits in healthy individuals: A positron emission tomography study with C-11 MDL100907","volume":"24","author":"Kim","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0835","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb0840","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.mp.4001851","article-title":"MAOA, maltreatment, and gene-environment interaction predicting children\u2019s mental health: New evidence and a meta-analysis","volume":"11","author":"Kim-Cohen","year":"2006","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0845","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"Kimura","year":"2019","journal-title":"Nature Structural & Molecular Biology"},{"issue":"Suppl. 2","key":"10.1016\/j.avb.2026.102139_bb0850","first-page":"17","article-title":"Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia","volume":"62","author":"Kinon","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0855","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors (Chur, Switzerland)"},{"key":"10.1016\/j.avb.2026.102139_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101875","article-title":"The role of monoamine oxidase a in the neurobiology of aggressive, antisocial, and violent behavior: A tale of mice and men","volume":"194","author":"Kolla","year":"2020","journal-title":"Progress in Neurobiology"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb0865","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(96)00723-8","article-title":"Enhanced 5-HT1A receptor expression in forebrain regions of aggressive house mice","volume":"736","author":"Korte","year":"1996","journal-title":"Brain Research"},{"issue":"8","key":"10.1016\/j.avb.2026.102139_bb0870","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0875","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowski","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0880","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/JCP.0b013e3181855cd6","article-title":"Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients","volume":"28","author":"Krakowski","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0885","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: The involvement of MAP kinases","volume":"86","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0890","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0269881117699617","article-title":"Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies","volume":"31","author":"Kuypers","year":"2017","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0895","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-5618.2011.00975.x","article-title":"Rapid acute treatment of agitation in patients with bipolar I disorder: A multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine","volume":"14","author":"Kwentus","year":"2012","journal-title":"Bipolar Disorders"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0900","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.11m07244","article-title":"Clozapine-induced agranulocytosis in Finland, 1982-2007: Long-term monitoring of patients is still warranted","volume":"73","author":"Lahdelma","year":"2012","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb0905","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2008-1077050","article-title":"Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder","volume":"41","author":"Lambert","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0910","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1192\/bjp.bp.110.081513","article-title":"Rapid acute treatment of agitation in individuals with schizophrenia: Multicentre, randomised, placebo-controlled study of inhaled loxapine","volume":"198","author":"Lesem","year":"2011","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"key":"10.1016\/j.avb.2026.102139_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111054","article-title":"Genetic polymorphisms in the 5-HT and endocannabinoid systems moderate the association between childhood trauma and burnout in the general occupational population","volume":"134","author":"Li","year":"2024","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb2915","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0893-133X(00)00126-3","article-title":"Psychological and Physiological Effects of MDMA (\u201cEcstasy\u201d) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans","volume":"23","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb0920","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4088\/JCP.v69n0617","article-title":"Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: A double-blind, placebo-controlled pilot study","volume":"69","author":"Linehan","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb0925","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0930","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/PL00005075","article-title":"Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907","volume":"356","author":"L\u00f3pez-Gim\u00e9nez","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb0935","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1046\/j.1460-9568.1999.00827.x","article-title":"Human striosomes are enriched in 5-HT2A receptors: Autoradiographical visualization with [3H]MDL100,907,[125I](+\/\u2212)DOI and [3H]ketanserin","volume":"11","author":"L\u00f3pez-Gim\u00e9nez","year":"1999","journal-title":"The European Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0940","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/1096-9861(20010122)429:4<571::AID-CNE5>3.0.CO;2-X","article-title":"Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies","volume":"429","author":"L\u00f3pez-Gim\u00e9nez","year":"2001","journal-title":"The Journal of Comparative Neurology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb0945","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuroimage.2006.09.028","article-title":"Evidence for a different role of the ventral and dorsal medial prefrontal cortex for social reactive aggression: An interactive fMRI study","volume":"34","author":"Lotze","year":"2007","journal-title":"NeuroImage"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb0950","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/j.avb.2026.102139_bb0955","series-title":"StatPearls","article-title":"Quetiapine","author":"Maan","year":"2025"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb0960","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pbb.2012.04.013","article-title":"Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice","volume":"102","author":"Machalova","year":"2012","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb0965","first-page":"297","article-title":"The impact of clozapine on 25 forensic patients","volume":"20","author":"Maier","year":"1992","journal-title":"The Bulletin of the American Academy of Psychiatry and the Law"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb0970","first-page":"395","article-title":"Restraint, seclusion, and clozapine","volume":"53","author":"Mallya","year":"1992","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb0975","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.biopsych.2008.11.021","article-title":"Candidate endophenotypes for genetic studies of suicidal behavior","volume":"65","author":"Mann","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb0980","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2018.02.002","article-title":"Effects of Para-methoxyamphetamine (PMA) on agonistic encounters between male mice","volume":"167","author":"Mart\u00edn-L\u00f3pez","year":"2018","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb0985","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/104454601317261564","article-title":"Prolactin levels in young children with pervasive developmental disorders during risperidone treatment","volume":"11","author":"Masi","year":"2001","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb0990","first-page":"1206","article-title":"Open trial of risperidone in 24 young children with pervasive developmental disorders","volume":"40","author":"Masi","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb0995","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4088\/JCP.v64n0909","article-title":"A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone","volume":"64","author":"Masi","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1000","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpsychires.2016.04.006","article-title":"Amygdala hyperactivation to angry faces in intermittent explosive disorder","volume":"79","author":"McCloskey","year":"2016","journal-title":"Journal of Psychiatric Research"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroscience.2007.01.047","article-title":"Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala","volume":"146","author":"McDonald","year":"2007","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1015","first-page":"685","article-title":"Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study","volume":"36","author":"McDougle","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.55.7.633","article-title":"A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders","volume":"55","author":"McDougle","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1025","series-title":"the Heffter review of psychedelic research","first-page":"65","article-title":"The scientific investigation of Ayahuasca: A review of past and current research","volume":"1","author":"McKenna","year":"1998"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4088\/JCP.v60n0504","article-title":"Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders. Seroquel trial 48 study group","volume":"60","author":"McManus","year":"1999","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1035","series-title":"StatPearls","article-title":"Risperidone","author":"McNeil","year":"2025"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0893-133X(01)00365-7","article-title":"Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: A double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology: Official publication of the American college of","volume":"26","author":"Meehan","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meehan","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acschemneuro.5b00023","article-title":"Cartography of 5-HT1A and 5-HT2A receptor subtypes in prefrontal cortex and its projections","volume":"6","author":"Mengod","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(90)90502-3","article-title":"Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites","volume":"524","author":"Mengod","year":"1990","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1139\/jpn.0847","article-title":"Serotonin2A receptor binding potential in people with aggressive and violent behaviour","volume":"33","author":"Meyer","year":"2008","journal-title":"Journal of Psychiatry & Neuroscience: JPN"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00004714-199306000-00008","article-title":"Clozapine response and adverse effects in nine brain-injured patients","volume":"13","author":"Michals","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb1070","series-title":"Biology of aggression","first-page":"114","article-title":"Monoamines, GABA, glutamate, and aggression","author":"Miczek","year":"2005"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1075","first-page":"399","article-title":"Brain 5-HT and inhibition of aggressive behavior in animals: 5-HIAA and receptor subtypes","volume":"25","author":"Miczek","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"Suppl. 2","key":"10.1016\/j.avb.2026.102139_bb1080","first-page":"3","article-title":"Atypical antipsychotics: Sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0306-4522(02)00580-8","article-title":"Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex","volume":"116","author":"Miner","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.avb.2026.102139_bb1090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2013.10.021","article-title":"Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action","volume":"79","author":"Mocci","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder","volume":"23","author":"Monnelly","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1257460","article-title":"Second-generation antipsychotics and metabolic syndrome: A role for mitochondria","volume":"14","author":"Mortimer","year":"2023","journal-title":"Frontiers in Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0091-3057(95)00351-7","article-title":"Effects of selective serotonergic agonists on aggressive behavior in rats","volume":"50","author":"Muehlenkamp","year":"1995","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1110","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.54","article-title":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","volume":"7","author":"Mueller","year":"2017","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1115","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","article-title":"Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance","volume":"175","author":"Munro","year":"1999","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1120","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3922\/j.psns.2014.4.20","article-title":"Aggressive behavior and three neurotransmitters: Dopamine, GABA, and serotonin\u2014A review of the last 10 years","volume":"7","author":"Narvaes","year":"2014","journal-title":"Psychology & Neuroscience"},{"key":"10.1016\/j.avb.2026.102139_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110542","article-title":"Serotonin 5-HT2A receptor polymorphisms are associated with irritability and aggression in conduct disorder","volume":"117","author":"Nedic Erjavec","year":"2022","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.avb.2026.102139_bb1130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(98)00483-X","article-title":"Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: A [35S]GTPgammaS binding study","volume":"355","author":"Newman-Tancredi","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1140","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chemical Reviews"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1145","first-page":"372","article-title":"An open trial of risperidone in young autistic children","volume":"37","author":"Nicolson","year":"1998","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021395","article-title":"Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network","volume":"6","author":"Niebert","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.avb.2026.102139_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110596","article-title":"Brain responses in aggression-prone individuals: A systematic review and meta-analysis of functional magnetic resonance imaging (fMRI) studies of anger- and aggression-eliciting tasks","volume":"119","author":"Nikolic","year":"2022","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2015.03.050","article-title":"Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex","volume":"297","author":"Nocjar","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00442239","article-title":"Serotonergic modulation of social interactions in isolated male mice","volume":"97","author":"Olivier","year":"1989","journal-title":"Psychopharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.avb.2026.102139_bb1170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979624","article-title":"Serotonin receptors and animal models of aggressive behavior","volume":"28","author":"Olivier","year":"1995","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.biopsych.2005.06.037","article-title":"Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide","volume":"59","author":"Oquendo","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/02698811231216322","article-title":"The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics","volume":"38","author":"Or\u0142owski","year":"2024","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"8","key":"10.1016\/j.avb.2026.102139_bb1185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/FPC.0b013e32832ee573","article-title":"Some molecular effectors of antidepressant action of quetiapine revealed by DNA microarray in the frontal cortex of anhedonic rats","volume":"19","author":"Orsetti","year":"2009","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.avb.2026.102139_bb1195","series-title":"Pharmacotheon Entheogenic drugs their plant sources and histories","author":"Ott","year":"2007"},{"key":"10.1016\/j.avb.2026.102139_bb1200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fphar.2018.00206","article-title":"Acute pharmacological effects of 2C-B in humans: An observational study","volume":"9","author":"Papaseit","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1205","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1017\/S0954579417001274","article-title":"Stress exposure and psychopathology alter methylation of the serotonin receptor 2A (HTR2A) gene in preschoolers","volume":"29","author":"Parade","year":"2017","journal-title":"Development and Psychopathology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1176\/appi.ps.53.3.348-a","article-title":"Clozapine and borderline personality disorder","volume":"53","author":"Parker","year":"2002","journal-title":"Psychiatric Services (Washington, D.C.)"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2004.06.020","article-title":"The \u20131438A\/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity","volume":"56","author":"Parsons","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: A review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-4522(87)90327-7","article-title":"Serotonin receptors in the human brain\u2014IV. Autoradiographic mapping of serotonin-2 receptors","volume":"21","author":"Pazos","year":"1987","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","article-title":"5-HT2C receptor structures reveal the structural basis of GPCR Polypharmacology","volume":"172","author":"Peng","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.avb.2026.102139_bb1235","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s00259-003-1250-x","article-title":"Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150","volume":"30","author":"Peremans","year":"2003","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12888-024-06303-z","article-title":"Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: A case report","volume":"25","author":"Perna","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: A systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"The Lancet. Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2009.06.080","article-title":"The lack of genotype-phenotype relationship between platelet serotonin concentration and serotonin transporter gene promoter polymorphism in healthy subjects","volume":"462","author":"Pivac","year":"2009","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1255","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/jnr.10173","article-title":"Differential expression of the \u201cC\u201d and \u201cT\u201d alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics","volume":"67","author":"Polesskaya","year":"2002","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of microdosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb1265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1270","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11055-010-9264-x","article-title":"Functional characteristics of serotonin 5-HT2A and 5-HT2C receptors in the brain and the expression of the 5-HT2A and 5-HT2C receptor genes in aggressive and non-aggressive rats","volume":"40","author":"Popova","year":"2010","journal-title":"Neuroscience and Behavioral Physiology"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11055-007-0062-z","article-title":"Involvement of brain serotonin 5-HT1A receptors in genetic predisposition to aggressive behavior","volume":"37","author":"Popova","year":"2007","journal-title":"Neuroscience and Behavioral Physiology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jnr.20456","article-title":"Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats","volume":"80","author":"Popova","year":"2005","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1285","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1037\/1040-3590.12.2.115","article-title":"Reactive and proactive aggression: Evidence of a two-factor model","volume":"12","author":"Poulin","year":"2000","journal-title":"Psychological Assessment"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/acps.12262","article-title":"A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation","volume":"130","author":"Pratts","year":"2014","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1295","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/2045125315581996","article-title":"An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service","volume":"5","author":"Qurashi","year":"2015","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-9964(96)00051-5","article-title":"Effect of clozapine on physical and verbal aggression","volume":"22","author":"Rabinowitz","year":"1996","journal-title":"Schizophrenia Research"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb1305","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jamapsychiatry.2015.1364","article-title":"Low resting heart rate as an unequivocal risk factor for both the perpetration of and exposure to violence","volume":"72","author":"Raine","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb1310","first-page":"1457","article-title":"Low resting heart rate at age 3 years predisposes to aggression at age 11 years: Evidence from the Mauritius child health project","volume":"36","author":"Raine","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1315","series-title":"Serotonin receptors in neurobiology","article-title":"Serotonin 2A (5-HT2A) receptor function: Ligand-dependent mechanisms and pathways","author":"Raote","year":"2007"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1320","first-page":"219","article-title":"The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital","volume":"54","author":"Ratey","year":"1993","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1325","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: Longer-term benefits and blinded discontinuation after 6 months","volume":"162","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2005","journal-title":"The American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.24869\/psyd.2019.157","article-title":"Asenapine: Pharmacological aspects and role in psychiatric disorders","volume":"31","author":"Reyad","year":"2019","journal-title":"Psychiatria Danubina"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1340","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(99)00049-X","article-title":"Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter","volume":"262","author":"Rioux","year":"1999","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1345","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/mol.64.5.1239","article-title":"Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor","volume":"64","author":"Robertson","year":"2003","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1350","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00429-023-02644-9","article-title":"Emotion, motivation, decision-making, the orbitofrontal cortex, anterior cingulate cortex, and the amygdala","volume":"228","author":"Rolls","year":"2023","journal-title":"Brain Structure & Function"},{"key":"10.1016\/j.avb.2026.102139_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104626","article-title":"Reactive vs proactive aggression: A differential psychobiological profile? Conclusions derived from a systematic review","volume":"136","author":"Romero-Mart\u00ednez","year":"2022","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1360","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/acps.12416","article-title":"Clozapine-induced myocarditis, a widely overlooked adverse reaction","volume":"132","author":"Ronaldson","year":"2015","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1365","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/15563650.2013.772191","article-title":"A case of 25I-NBOMe (25-I) intoxication: A new potent 5-HT2A agonist designer drug","volume":"51","author":"Rose","year":"2013","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"12","key":"10.1016\/j.avb.2026.102139_bb1370","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.biopsych.2010.03.013","article-title":"Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients","volume":"67","author":"Rosell","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1375","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb1380","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1358\/dnp.2007.20.9.1162244","article-title":"5-HT2C receptor agonists as an innovative approach for psychiatric disorders","volume":"20","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Drug News & Perspectives"},{"issue":"24","key":"10.1016\/j.avb.2026.102139_bb1385","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.3390\/ijms21249362","article-title":"Understanding mechanisms underlying non-alcoholic fatty liver disease (NAFLD) in mental illness: Risperidone and olanzapine Alter the hepatic proteomic signature in mice","volume":"21","author":"Rostama","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.avb.2026.102139_bb1390","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12863-015-0325-6","article-title":"Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: Identification of novel HTR2A and antisense (HTR2A-AS1) exons","volume":"17","author":"Ruble","year":"2016","journal-title":"BMC Genetics"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1395","doi-asserted-by":"crossref","first-page":"162","DOI":"10.12788\/acp.0032","article-title":"Inhaled loxapine for acute agitation in a psychiatric emergency service","volume":"33","author":"Ruch","year":"2021","journal-title":"Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/phrs.2000.0790","article-title":"Acute trazodone and quipazine treatment attenuates apomorphine-induced aggressive behaviour in male rats without major impact on emotional behaviour or monoamine content post mortem","volume":"43","author":"Rudissaar","year":"2001","journal-title":"Pharmacological Research"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1405","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/YPG.0b013e3283050ada","article-title":"Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts","volume":"18","author":"Saiz","year":"2008","journal-title":"Psychiatric Genetics"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1415","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1254\/jjp.89.89","article-title":"Modulation by 5-hT2A receptors of aggressive behavior in isolated mice","volume":"89","author":"Sakaue","year":"2002","journal-title":"Japanese Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1420","first-page":"151","article-title":"Systematic review and Meta-analysis: Efficacy of pharmacological interventions for irritability and emotional dysregulation in autism Spectrum disorder and predictors of response","volume":"62","author":"Salazar de Pablo","year":"2023","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb1425","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02246950","article-title":"The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice","volume":"110","author":"S\u00e1nchez","year":"1993","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1430","first-page":"15","article-title":"Breaking the stigma: A systematic review of antipsychotic efficacy in children and adolescents with behavioral disorders","volume":"12","author":"Sanfins","year":"2025","journal-title":"Medicines (Basel, Switzerland)"},{"key":"10.1016\/j.avb.2026.102139_bb1435","article-title":"Cannabidiol for treatment of irritability and aggressive behavior in children and adolescents with ASD: Background and methods of the CAnnabidiol Study in Children with Autism Spectrum DisordEr (CASCADE) study","author":"Sannar","year":"2024","journal-title":"medRxiv: The Preprint Server for Health Sciences"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1440","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1017\/S1461145712001083","article-title":"Expression of \u03b1(1)-adrenergic receptors in rat prefrontal cortex: Cellular co-localization with 5-HT(2A) receptors","volume":"16","author":"Santana","year":"2013","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"5180","key":"10.1016\/j.avb.2026.102139_bb1445","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.8091214","article-title":"Enhanced aggressive behavior in mice lacking 5-HT1B receptor","volume":"265","author":"Saudou","year":"1994","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1450","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00726-011-1078-9","article-title":"Serotonin and molecular neuroimaging in humans using PET","volume":"42","author":"Saulin","year":"2012","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1455","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuroimage.2012.07.001","article-title":"Normative database of the serotonergic system in healthy subjects using multi-tracer PET","volume":"63","author":"Savli","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.avb.2026.102139_bb1460","article-title":"Aggressive behaviours associated with MDMA and psychedelics: A narrative review","volume":"37","author":"Sayrafizadeh","year":"2024","journal-title":"Acta Neuropsychiatrica"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1465","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0091-3057(78)90385-4","article-title":"Mescaline produces pathological aggression in rats regardless of age or strain","volume":"8","author":"Sbordone","year":"1978","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1470","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00428319","article-title":"Severe aggression in rats induced by mescaline but not other hallucinogens","volume":"66","author":"Sbordone","year":"1979","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1475","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13651501.2025.2560357","article-title":"Asenapine for aggressive behaviours in psychiatric disorders: A systematic review of efficacy and real-world effectiveness","volume":"29","author":"Scala","year":"2025","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1480","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00002093-200204000-00011","article-title":"Cognitive and behavioral effects of quetiapine in Alzheimer disease patients","volume":"16","author":"Scharre","year":"2002","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.avb.2026.102139_bb1485","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fphar.2018.00733","article-title":"Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric Research and Development","volume":"9","author":"Schenberg","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"40","key":"10.1016\/j.avb.2026.102139_bb1490","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1523\/JNEUROSCI.1665-10.2010","article-title":"Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a \u00df-arrestin2\/Src\/Akt signaling complex in vivo","volume":"30","author":"Schmid","year":"2010","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"15","key":"10.1016\/j.avb.2026.102139_bb1495","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb1500","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1505","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cne.902890111","article-title":"Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult rat","volume":"289","author":"S\u00e9gu\u00e9la","year":"1989","journal-title":"The Journal of Comparative Neurology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb2505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: A novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb1510","series-title":"StatPearls","article-title":"Trazodone","author":"Shin","year":"2025"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb1515","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tibs.2011.06.003","article-title":"Emerging paradigms of \u03b2-arrestin-dependent seven transmembrane receptor signaling","volume":"36","author":"Shukla","year":"2011","journal-title":"Trends in Biochemical Sciences"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1520","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S1461145708009590","article-title":"Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907","volume":"12","author":"Singh","year":"2009","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1525","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archpsyc.1997.01830180067009","article-title":"Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel study group","volume":"54","author":"Small","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb1530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00429-008-0176-2","article-title":"The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala","volume":"213","author":"Smith","year":"2008","journal-title":"Brain Structure & Function"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1535","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2012.09.028","article-title":"Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex","volume":"73","author":"Smith","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1540","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pscychresns.2009.08.007","article-title":"Gender, personality, and serotonin-2A receptor binding in healthy subjects","volume":"181","author":"Soloff","year":"2010","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.avb.2026.102139_bb1545","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.sleep.2021.02.038","article-title":"Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: A double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson\u2019s disease dementia","volume":"81","author":"Stefani","year":"2021","journal-title":"Sleep Medicine"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1550","first-page":"89","article-title":"Transdermal Asenapine for agitation and irritability in a child with complete intravenous dependence","volume":"64","author":"Stimpfl","year":"2025","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1555","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S1092852915000784","article-title":"Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital","volume":"21","author":"Stone-Brown","year":"2016","journal-title":"CNS Spectrums"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb1560","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial. The HGEU study group","volume":"57","author":"Street","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1565","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/scan\/nsp036","article-title":"Developmental effects of aggressive behavior in male adolescents assessed with structural and functional brain imaging","volume":"6","author":"Strenziok","year":"2011","journal-title":"Social Cognitive and Affective Neuroscience"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1570","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0091-3057(86)90056-0","article-title":"Must antidepressants be anticholinergic to inhibit muricide?","volume":"24","author":"Strickland","year":"1986","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1575","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00019442-200409000-00009","article-title":"A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances","volume":"12","author":"Suh","year":"2004","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1580","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00019442-199705010-00008","article-title":"A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia","volume":"5","author":"Sultzer","year":"1997","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"10","key":"10.1016\/j.avb.2026.102139_bb1585","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1046\/j.1532-5415.2001.49256.x","article-title":"Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?","volume":"49","author":"Sultzer","year":"2001","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094657","article-title":"Control of intermale aggression by medial prefrontal cortex activation in the mouse","volume":"9","author":"Takahashi","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb1595","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0149-2918(00)80085-5","article-title":"Long-term use of quetiapine in elderly patients with psychotic disorders","volume":"22","author":"Tariot","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"S31","key":"10.1016\/j.avb.2026.102139_bb1600","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1192\/S0007125000298589","article-title":"Schizophrenia, violence, clozapine and risperidone: A review","volume":"169","author":"The Special Hospitals Treatment Resistant Schizophrenia Research Group","year":"1996","journal-title":"The British Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1605","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0269881118771782","article-title":"Psychedelic use and intimate partner violence: The role of emotion regulation","volume":"32","author":"Thiessen","year":"2018","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.avb.2026.102139_bb1610","series-title":"StatPearls","article-title":"Olanzapine","author":"Thomas","year":"2025"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1615","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.154.4.457","article-title":"Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial","volume":"154","author":"Tollefson","year":"1997","journal-title":"The American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1620","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2007.11.014","article-title":"Impulsivity, compulsivity, and habit: The role of orbitofrontal cortex revisited","volume":"63","author":"Torregrossa","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1625","first-page":"126","article-title":"A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients","volume":"47","author":"Tuason","year":"1986","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1630","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2045125314566808","article-title":"Clozapine prescribing in the UK: Views and experience of consultant psychiatrists","volume":"5","author":"Tungaraza","year":"2015","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb1635","doi-asserted-by":"crossref","DOI":"10.1016\/j.rasd.2020.101520","article-title":"Olanzapine, risperidone, and aripiprazole use in children and adolescents with autism Spectrum disorders","volume":"72","author":"Tural Hesapcioglu","year":"2020","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1640","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","article-title":"Psilocybin \u2013 Summary of knowledge and new perspectives","volume":"24","author":"Tyl\u0161","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1650","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(86)90133-4","article-title":"Pharmaco-ethological analysis of antidepressant drug effects","volume":"25","author":"Valdman","year":"1986","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.avb.2026.102139_bb1655","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: The forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1660","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/104454601750143348","article-title":"Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: A double-blind, placebo-controlled pilot trial","volume":"11","author":"Van Bellinghen","year":"2001","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.avb.2026.102139_bb1665","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(93)90077-Z","article-title":"Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens","volume":"624","author":"Van Bockstaele","year":"1993","journal-title":"Brain Research"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1670","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cercor\/bhn204","article-title":"Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors","volume":"19","author":"V\u00e1zquez-Borsetti","year":"2009","journal-title":"Cerebral Cortex (New York, N.Y.: 1991)"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1675","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaac.2016.04.014","article-title":"The status of irritability in psychiatry: A conceptual and quantitative review","volume":"55","author":"Vidal-Ribas","year":"2016","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1680","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2024.2346132","article-title":"Religion, psychedelics, risky behavior, and violence","volume":"57","author":"Vi\u00f1a","year":"2025","journal-title":"Journal of Psychoactive Drugs"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002194","article-title":"Cognitive impairment induced by Delta9-tetrahydrocannabinol occurs through Heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors","volume":"13","author":"Vi\u00f1als","year":"2015","journal-title":"PLoS Biology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1690","first-page":"271","article-title":"Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence","volume":"20","author":"Virkkunen","year":"1995","journal-title":"Journal of Psychiatry & Neuroscience: JPN"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1695","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4088\/JCP.10m06529","article-title":"Efficacy of antipsychotic drugs against hostility in the European first-episode schizophrenia trial (EUFEST)","volume":"72","author":"Volavka","year":"2011","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1700","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.jcp.0000117424.05703.29","article-title":"Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol","volume":"24","author":"Volavka","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1705","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":"Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder","volume":"159","author":"Volavka","year":"2002","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.avb.2026.102139_bb1710","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eurpsy.2015.10.003","article-title":"Hostility in schizophrenia: An integrated analysis of the combined clinical antipsychotic trials of intervention effectiveness (CATIE) and the European first episode schizophrenia trial (EUFEST) studies","volume":"31","author":"Volavka","year":"2016","journal-title":"European Psychiatry: The Journal of the Association of European Psychiatrists"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1715","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00004714-199308000-00012","article-title":"Clozapine effects on hostility and aggression in schizophrenia","volume":"13","author":"Volavka","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.avb.2026.102139_bb1720","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002130050960","article-title":"Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans","volume":"143","author":"Vollenweider","year":"1999","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1725","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1730","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0306624X03253027","article-title":"Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine","volume":"47","author":"Walker","year":"2003","journal-title":"International Journal of Offender Therapy and Comparative Criminology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1735","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","article-title":"Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential","volume":"14","author":"Wallach","year":"2023","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1740","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/0269881116642538","article-title":"Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use","volume":"30","author":"Walsh","year":"2016","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1745","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cellsig.2014.12.019","article-title":"PDZK1\/NHERF3 differentially regulates corticotropin-releasing factor receptor 1 and serotonin 2A receptor signaling and endocytosis","volume":"27","author":"Walther","year":"2015","journal-title":"Cellular Signalling"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1750","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R","article-title":"Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum","volume":"370","author":"Ward","year":"1996","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.avb.2026.102139_bb1755","first-page":"36","article-title":"Htr2a gene and 5-HT(2A) receptor expression in the cerebral cortex studied using genetically modified mice","volume":"4","author":"Weber","year":"2010","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1760","first-page":"229","article-title":"A search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices\u2014Immunohistochemical studies","volume":"59","author":"Wedzony","year":"2008","journal-title":"Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society"},{"issue":"16_supplement","key":"10.1016\/j.avb.2026.102139_bb1765","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.P6.088","article-title":"A phase 2 study of Nelotanserin, a novel 5HT2A receptor inverse agonist, in dementia with Lewy bodies and Parkinson\u2019s disease dementia subjects experiencing visual hallucinations (P6.088)","volume":"88","author":"Wen","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.avb.2026.102139_bb1770","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0091-3057(91)90155-U","article-title":"Effects of serotonergic agents on isolation-induced aggression","volume":"39","author":"White","year":"1991","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1775","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","article-title":"Seizure associated with clozapine: Incidence, etiology, and management","volume":"29","author":"Williams","year":"2015","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1780","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A","article-title":"Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex","volume":"27","author":"Willins","year":"1997","journal-title":"Synapse (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1785","first-page":"700","article-title":"Clinical review of clozapine treatment in a state hospital","volume":"43","author":"Wilson","year":"1992","journal-title":"Hospital & Community Psychiatry"},{"issue":"9","key":"10.1016\/j.avb.2026.102139_bb1790","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/cap.2015.0216","article-title":"Clozapine for drug-refractory irritability in individuals with developmental disability","volume":"26","author":"Wink","year":"2016","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"7","key":"10.1016\/j.avb.2026.102139_bb1795","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright","year":"2001","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1800","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.psychres.2011.04.027","article-title":"Association of polymorphisms in HTR2A, HTR1A and TPH2 genes with suicide attempts in alcohol dependence: A preliminary report","volume":"190","author":"Wrzosek","year":"2011","journal-title":"Psychiatry Research"},{"issue":"24","key":"10.1016\/j.avb.2026.102139_bb1805","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1074\/jbc.M301905200","article-title":"A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction","volume":"278","author":"Xia","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1810","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5152\/pcp.2025.24944","article-title":"Efficacy and safety of risperidone interventions in children and adolescents with autism Spectrum disorder","volume":"35","author":"Yang","year":"2025","journal-title":"Psychiatry and Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1815","first-page":"147","article-title":"Risperidone beyond psychoses","volume":"1","author":"Yoon","year":"2003","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"key":"10.1016\/j.avb.2026.102139_bb1820","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.euroneuro.2024.04.010","article-title":"Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression","volume":"83","author":"Zacher","year":"2024","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb1825","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/jpet.087.985400","article-title":"Serendipitous discovery of novel 5-HT2AR positive allosteric modulators (PAMs) derived from 5-HT2CR PAM scaffolds","volume":"389","author":"Zamora","year":"2024","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1830","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2045125313484323","article-title":"Clozapine for self-injurious behavior in individuals with borderline personality disorder","volume":"3","author":"Zarzar","year":"2013","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"6","key":"10.1016\/j.avb.2026.102139_bb1835","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jnc.12055","article-title":"Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner","volume":"123","author":"Zhang","year":"2012","journal-title":"Journal of Neurochemistry"},{"issue":"7 Pt 1","key":"10.1016\/j.avb.2026.102139_bb1840","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1523\/JNEUROSCI.15-07-04885.1995","article-title":"Characterization of the human 5-HT2A receptor gene promoter","volume":"15","author":"Zhu","year":"1995","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"1","key":"10.1016\/j.avb.2026.102139_bb1845","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1038\/s41598-019-44115-4","article-title":"Brain structures and functional connectivity associated with individual differences in trait proactive aggression","volume":"9","author":"Zhu","year":"2019","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.avb.2026.102139_bb1850","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00004714-199210000-00010","article-title":"Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children","volume":"12","author":"Zubieta","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.avb.2026.102139_bb1855","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/cap.2000.10.79","article-title":"Long-term risperidone for pervasive developmental disorder: Efficacy, tolerability, and discontinuation","volume":"10","author":"Zuddas","year":"2000","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.avb.2026.102139_bb2855","series-title":"Handbook of Behavioral Neuroscience","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1569-7339(10)70079-5","article-title":"The Degradation of Serotonin: Role of MAO","volume":"Vol. 21","author":"Bortolato","year":"2010"},{"issue":"D1","key":"10.1016\/j.avb.2026.102139_bb2860","doi-asserted-by":"crossref","first-page":"D1446","DOI":"10.1093\/nar\/gkaf1067","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2026","volume":"54","author":"Harding","year":"2026","journal-title":"Nucleic Acids Research"}],"container-title":["Aggression and Violent Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359178926000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359178926000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:52:35Z","timestamp":1777611155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359178926000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":370,"alternative-id":["S1359178926000145"],"URL":"https:\/\/doi.org\/10.1016\/j.avb.2026.102139","relation":{},"ISSN":["1359-1789"],"issn-type":[{"value":"1359-1789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting serotonin 5-HT2A receptors in the treatment of aggression: From antipsychotics to psychedelics","name":"articletitle","label":"Article Title"},{"value":"Aggression and Violent Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avb.2026.102139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102139"}}